Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.

Yamanaka, R; Zullo, S A; Tanaka, R; Blaese, M; Xanthopoulos, K G

Yamanaka, R; Zullo, S A; Tanaka, R; Blaese, M; Xanthopoulos, K G.

Affiliation

Yamanaka R; Clinical Gene Therapy Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. ryaman@pop11.odn.ne.jp

J Neurosurg ; 94(3): 474-81, 2001 Mar.

Article in En | MEDLINE | ID: mdl-11235953

Subject(s)

Brain Neoplasms/therapy; Dendritic Cells/immunology; Genetic Therapy/methods; Genetic Vectors; Glioma/therapy; Immunotherapy/methods; Semliki forest virus; Animals; Apoptosis/genetics; Apoptosis/immunology; Bone Marrow Cells/cytology; Brain Neoplasms/mortality; CD8-Positive T-Lymphocytes/immunology; DNA, Complementary; Dendritic Cells/cytology; Glioma/mortality; Immunization; Melanoma; Mice; Mice, Inbred C57BL; Survival Rate; Transfection; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Semliki forest virus / Dendritic Cells / Brain Neoplasms / Genetic Therapy / Genetic Vectors / Glioma / Immunotherapy Limits: Animals Language: En Journal: J Neurosurg Year: 2001 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links